Comparative Pharmacology
Head-to-head clinical analysis: FREAMINE 8 5 versus FREAMINE III 8 5 W ELECTROLYTES.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FREAMINE 8 5 versus FREAMINE III 8 5 W ELECTROLYTES.
FREAMINE 8.5% vs FREAMINE III 8.5% W/ ELECTROLYTES
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
FREAMINE 8.5% is a crystalline amino acid solution that provides essential and nonessential amino acids for protein synthesis, maintenance of nitrogen balance, and tissue repair in patients unable to tolerate oral or enteral nutrition.
FREAMINE III 8.5% W/ ELECTROLYTES is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis, promoting nitrogen balance and tissue maintenance in patients unable to tolerate oral/enteral nutrition.
1 to 2 g/kg/day intravenously, typical adult dose 70-140 g/day (800-1650 mL of 8.5% solution), infused at a rate not exceeding 0.1 g/kg/hour
Intravenous infusion: 1.0-1.5 g amino acids/kg/day (equivalent to 12-18 mL/kg/day of 8.5% solution). Administer via central or peripheral line. Typical adult dose: 500-1000 mL/day infused at 125-200 mL/hour.
None Documented
None Documented
The terminal elimination half-life of infused amino acids is not conventionally defined as it depends on metabolic utilization. For most amino acids, plasma clearance is rapid (minutes to hours) with a pseudo-half-life of approximately 15-30 minutes for the initial distribution phase. Clinical context: half-life is irrelevant since amino acids are continuously metabolized and incorporated into proteins.
Not applicable as a composite mixture; individual amino acid half-lives vary from minutes to hours. Clinical context: continuous infusion used for metabolic support.
Amino acids from FREAMINE 8.5% are primarily metabolized via deamination and transamination pathways, with nitrogen waste excreted renally as urea (approx 80-90% of administered nitrogen). A small fraction is excreted via feces as unabsorbed amino acids (less than 5%). Biliary excretion is negligible.
Renal (primarily as urea and ammonia); 100% of infused amino acids are metabolized or excreted renally. Fecal excretion negligible.
Category C
Category C
Parenteral nutrition amino acid
Parenteral nutrition amino acid